S Hartmann
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
Horn H, Hansmann M, Möller P, Cogliatti S, Pfreundschuh M, Trümper L, Loeffler M, Glass B, Schmitz N, Ott G, Rosenwald A, Hartmann S, Lenze D, Ziepert M, Wartenberg M, Staiger A, Barth T, Bernd H, Feller A, Klapper W, Stuhlmann-Laeisz C, Hummel M, Stein H, DSHNHL16. Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma. Leukemia 2015; 29:1564-70.
17.02.2015Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
17.02.2015Leukemia 2015; 29:1564-70
Horn H, Hansmann M-L, Möller P, Cogliatti Sergio B., Pfreundschuh M, Trümper L, Loeffler M, Glass B, Schmitz N, Ott G, Rosenwald A, Hartmann S, Lenze D, Ziepert M, Wartenberg M, Staiger A M, Barth T F E, Bernd H-W, Feller A C, Klapper W, Stuhlmann-Laeisz C, Hummel M, Stein H, DSHNHL16
[Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization]
Barth T, Thorns C, Stein H, Rosenwald A, Möller P, Mattfeldt T, Kradolfer D, Klapper W, Horn H, Hartmann S, Hansmann M, Feller A, Cogliatti S, Buck M, Bob R, Bernd H, Floßbach L, Ott G. [Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization]. Pathologe 2013; 34:329-34.
01.07.2013[Round robin test for detection of genomic aberrations in non-Hodgkin lymphoma by in situ hybridization]
01.07.2013Pathologe 2013; 34:329-34
Barth T F E, Thorns C, Stein H, Rosenwald A, Möller P, Mattfeldt T, Kradolfer D, Klapper W, Horn H, Hartmann S, Hansmann M L, Feller A C, Cogliatti Sergio B., Buck M, Bob R, Bernd H-W, Floßbach L, Ott G
[Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses]
Hartmann S, Cogliatti S, Hansmann M. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses]. Pathologe 2013; 34:233-43.
01.05.2013[Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses]
01.05.2013Pathologe 2013; 34:233-43
Hartmann S, Cogliatti Sergio B., Hansmann M-L
Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial
Bauer M, Czell D, Hartmann S, Goldman B, Müller D, Weber M. Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial. Respiration 2012; 84:306-11.
28.07.2012Limitations of sniff nasal pressure as an outcome measurement in amyotrophic lateral sclerosis patients in a clinical trial
28.07.2012Respiration 2012; 84:306-11
Bauer M, Czell David, Hartmann S, Goldman B, Müller D, Weber Markus